FourWorld Capital Management’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,020,910	Closed	-$4.63M	–	23
2025 Q3	$4.63M	Sell	1,020,910 -205,800	-17%	-$756K	11.23%	4
2025 Q2	$3.79M	Hold	1,226,710	–	–	2.72%	7
2025 Q1	$4.28M	Hold	1,226,710	–	–	2.94%	6
2024 Q4	$4.01M	Sell	1,226,710 -1,745,817	-59%	-$6.42M	2.09%	6
2024 Q3	$11.4M	Hold	2,972,527	–	–	10.13%	4
2024 Q2	$9.19M	Sell	2,972,527 -28,000	-0.9%	-$84K	11.46%	5
2024 Q1	$7.74M	Buy	3,000,527 +1,909,676	+175%	+$4.95M	6.83%	6
2023 Q4	$2.73M	Sell	1,090,851 -251,056	-19%	-$492K	3.58%	10
2023 Q3	$2.72M	Hold	1,341,907	–	–	0.87%	18
2023 Q2	$3.09M	Sell	1,341,907 -658,183	-33%	-$1.71M	0.89%	15
2023 Q1	$6.06M	Hold	2,000,090	–	–	3.8%	12
2022 Q4	$4.66M	Hold	2,000,090	–	–	6.74%	5
2022 Q3	$3.82M	Buy	2,000,090 +199,090	+11%	+$469K	7.43%	6
2022 Q2	$4.88M	Buy	1,801,000 +253,261	+16%	+$648K	8.31%	4
2022 Q1	$4.61M	Buy	+1,547,739	New	+$4.74M	2.86%	5